- Home
- ORIC vs NAGE Comparison
ORIC vs NAGE Comparison
Compare ORIC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- NAGE
- Stock Information
- Founded
- ORIC 2014
- NAGE 1999
- Country
- ORIC United States
- NAGE United States
- Employees
- ORIC N/A
- NAGE N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- ORIC Health Care
- NAGE Health Care
- Exchange
- ORIC Nasdaq
- NAGE Nasdaq
- Market Cap
- ORIC 974.1M
- NAGE 861.0M
- IPO Year
- ORIC 2020
- NAGE N/A
- Fundamental
- Price
- ORIC $10.88
- NAGE $9.41
- Analyst Decision
- ORIC Strong Buy
- NAGE Strong Buy
- Analyst Count
- ORIC 10
- NAGE 3
- Target Price
- ORIC $17.33
- NAGE $17.00
- AVG Volume (30 Days)
- ORIC 782.2K
- NAGE 899.3K
- Earning Date
- ORIC 08-12-2025
- NAGE 10-30-2025
- Dividend Yield
- ORIC N/A
- NAGE N/A
- EPS Growth
- ORIC N/A
- NAGE N/A
- EPS
- ORIC N/A
- NAGE 0.22
- Revenue
- ORIC N/A
- NAGE $116,303,000.00
- Revenue This Year
- ORIC N/A
- NAGE $28.46
- Revenue Next Year
- ORIC N/A
- NAGE $21.65
- P/E Ratio
- ORIC N/A
- NAGE $43.58
- Revenue Growth
- ORIC N/A
- NAGE 35.90
- 52 Week Low
- ORIC $3.90
- NAGE $3.13
- 52 Week High
- ORIC $14.67
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- ORIC 63.04
- NAGE 40.69
- Support Level
- ORIC $9.87
- NAGE $9.50
- Resistance Level
- ORIC $10.35
- NAGE $9.97
- Average True Range (ATR)
- ORIC 0.44
- NAGE 0.40
- MACD
- ORIC 0.14
- NAGE 0.00
- Stochastic Oscillator
- ORIC 79.99
- NAGE 25.45
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.